Check out “Heard on the Street” recorded during IDS Paris 2023. Hear from Dr. David Klatzmann from Sorbonne University as he discusses his thoughts on the conference and discusses his thoughts on new treatments for type one diabetes.

Check out “Heard on the Street” recorded during IDS Paris 2023. Hear from Dr. Emma Hamilton-Williams from University of Queensland as she discusses her thoughts on the conference.

Check out “Heard on the Street” recorded during IDS Paris 2023. Hear from Dr. Raffael Ott from Helmholtz Munich as he discusses his poster on Maternal type 1 diabetes is associated with blood DNA methylation changes in young offspring.

Check out “Heard on the Street” recorded during IDS Paris 2023. Hear from PhD student Gabriele Sassi from KU Leuven as he discusses his thoughts on the conference.

Check out “Heard on the Street” recorded during IDS Paris 2023. Hear from Dr. Irina Buckle from University of Queensland as she discusses her poster on Targeting RAGE using an oral antagonist to prevent Type 1 diabetes in NOD mice.

Check out “Heard on the Street” recorded during IDS Paris 2023. Hear from Dr. David Repaske from University of Virginia as he discusses his thoughts on the conference.

Check out “Heard on the Street” recorded during IDS Paris 2023. Hear from Ms. Coralie Alabert and Mr. Mathias Høj Jensen as they share their thoughts on the conference from a patient perspective.

Check out “Heard on the Street” recorded during IDS Paris 2023. Hear from Dr. Chantal Mathieu from Katholieke Universiteit as she discusses her thoughts on the conference and the next steps for INNODIA.

Check out “Heard on the Street” recorded during IDS Paris 2023. Hear from Dr. Lauren Higdon from the Immune Tolerance Network as she discusses her poster on Aged T cells are increased in new onset type 1 diabetes patients.

Check out “Heard on the Street” recorded during IDS Paris 2023. Hear from PhD candidate Mathias Jensen from University of Copenhagen as he discusses his poster on Pancreatic dysregulation of innate antiviral immune pathways in type 1 diabetes.